Combining Quantitative Susceptibility Mapping with Automatic Zero Reference (QSM0) and Myelin Water Fraction Imaging to Quantify Iron-Related Myelin Damage in Chronic Active MS Lesions

References

1. 1.↵
   2. Bagnato F,
   3. Hametner S,
   4. Yao B, et al

   . Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla. Brain 2011;134:3602–15 doi:10.1093/brain/awr278 pmid:22171355

   CrossRefPubMed
2. 2.↵
   2. Stephenson E,
   3. Nathoo N,
   4. Mahjoub Y, et al

   . Iron in multiple sclerosis: roles in neurodegeneration and repair. Nat Rev Neurol 2014;10:459–68 doi:10.1038/nrneurol.2014.118 pmid:25002107

   CrossRefPubMed
3. 3.↵
   2. Dal-Bianco A,
   3. Grabner G,
   4. Kronnerwetter C, et al

   . Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging. Acta Neuropathol 2017;133:25–42 doi:10.1007/s00401-016-1636-z pmid:27796537

   CrossRefPubMed
4. 4.↵
   2. Absinta M,
   3. Sati P,
   4. Schindler M, et al

   . Persistent 7-Tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions. J Clin Invest 2016;126:2597–609 doi:10.1172/JCI86198 pmid:27270171

   CrossRefPubMed
5. 5.↵
   2. Cairo G,
   3. Recalcati S,
   4. Mantovani A, et al

   . Iron trafficking and metabolism in macrophages: contribution to the polarized phenotype. Trends Immunol 2011;32:241–47 doi:10.1016/j.it.2011.03.007 pmid:21514223

   CrossRefPubMedWeb of Science
6. 6.↵
   2. Langkammer C,
   3. Schweser F,
   4. Krebs N, et al

   . Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study. Neuroimage 2012;62:1593–99 doi:10.1016/j.neuroimage.2012.05.049 pmid:22634862

   CrossRefPubMed
7. 7.↵
   2. Hammond KE,
   3. Metcalf M,
   4. Carvajal L, et al

   . Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron. Ann Neurol 2008;64:707–13 doi:10.1002/ana.21582 pmid:19107998

   CrossRefPubMedWeb of Science
8. 8.↵
   2. Yao B,
   3. Ikonomidou VN,
   4. Cantor FK, et al

   . Heterogeneity of multiple sclerosis white matter lesions detected with T2*-weighted imaging at 7.0 Tesla. J Neuroimaging 2015;25:799–806 doi:10.1111/jon.12193 pmid:25657078

   CrossRefPubMed
9. 9.↵
   2. Mehta V,
   3. Pei W,
   4. Yang G, et al

   . Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions. PLoS One 2013;8:e57573 doi:10.1371/journal.pone.0057573 pmid:23516409

   CrossRefPubMed
10. 10.↵
    2. Haacke EM,
    3. Makki M,
    4. Ge Y, et al

    . Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging. J Magn Reson Imaging 2009;29:537–44 doi:10.1002/jmri.21676 pmid:19243035

    CrossRefPubMed
11. 11.↵
    2. Langkammer C,
    3. Krebs N,
    4. Goessler W, et al

    . Quantitative MR imaging of brain iron: a postmortem validation study. Radiology 2010;257:455–62 doi:10.1148/radiol.10100495 pmid:20843991

    CrossRefPubMedWeb of Science
12. 12.↵
    2. Li J,
    3. Chang S,
    4. Liu T, et al

    . Reducing the object orientation dependence of susceptibility effects in gradient echo MRI through quantitative susceptibility mapping. Magn Reson Med 2012;68:1563–69 doi:10.1002/mrm.24135 pmid:22851199

    CrossRefPubMed
13. 13.↵
    2. Hopp K,
    3. Popescu BF,
    4. McCrea RP, et al

    . Brain iron detected by SWI high pass filtered phase calibrated with synchrotron X-ray fluorescence. J Magn Reson Imaging 2010;31:1346–54 doi:10.1002/jmri.22201 pmid:20512886

    CrossRefPubMed
14. 14.↵
    2. Wiggermann V,
    3. Hametner S,
    4. Hernandez-Torres E, et al

    . Susceptibility-sensitive MRI of multiple sclerosis lesions and the impact of normal-appearing white matter changes. NMR Biomed 2017;30 doi:10.1002/nbm.3727 pmid:28470768

    CrossRefPubMed
15. 15.↵
    2. Eskreis-Winkler S,
    3. Deh K,
    4. Gupta A, et al

    . Multiple sclerosis lesion geometry in quantitative susceptibility mapping (QSM) and phase imaging. J Magn Reson Imaging 2015;42:224–29 doi:10.1002/jmri.24745 pmid:25174493

    CrossRefPubMed
16. 16.↵
    2. Wang Y,
    3. Liu T

    . Quantitative susceptibility mapping (QSM): decoding MRI data for a tissue magnetic biomarker. Magn Reson Med 2015;73:82–101 doi:10.1002/mrm.25358 pmid:25044035

    CrossRefPubMed
17. 17.↵
    2. Wisnieff C,
    3. Ramanan S,
    4. Olesik J, et al

    . Quantitative susceptibility mapping (QSM) of white matter multiple sclerosis lesions: interpreting positive susceptibility and the presence of iron. Magn Reson Med 2015;74:564–70 doi:10.1002/mrm.25420 pmid:25137340

    CrossRefPubMed
18. 18.↵
    2. Stuber C,
    3. Pitt D,
    4. Wang Y

    . Iron in multiple sclerosis and its noninvasive imaging with quantitative susceptibility mapping. Int J Mol Sci 2016;17:E100 doi:10.3390/ijms17010100 pmid:26784172

    CrossRefPubMed
19. 19.↵
    2. Deistung A,
    3. Schäfer A,
    4. Schweser F, et al

    . Toward in vivo histology: a comparison of quantitative susceptibility mapping (QSM) with magnitude-, phase-, and R2*-imaging at ultra-high magnetic field strength. Neuroimage 2013;65:299–314 doi:10.1016/j.neuroimage.2012.09.055 pmid:23036448

    CrossRefPubMed
20. 20.↵
    2. Langkammer C,
    3. Liu T,
    4. Khalil M, et al

    . Quantitative susceptibility mapping in multiple sclerosis. Radiology 2013;267:551–59 doi:10.1148/radiol.12120707 pmid:23315661

    CrossRefPubMedWeb of Science
21. 21.↵
    2. Zhang Y,
    3. Gauthier SA,
    4. Gupta A, et al

    . Quantitative susceptibility mapping and R2* measured changes during white matter lesion development in multiple sclerosis: myelin breakdown, myelin debris degradation and removal, and iron accumulation. AJNR Am J Neuroradiol 2016;37:1629–35 doi:10.3174/ajnr.A4825 pmid:27256856

    Abstract/FREE Full Text
22. 22.↵
    2. Li X,
    3. Harrison DM,
    4. Liu H, et al

    . Magnetic susceptibility contrast variations in multiple sclerosis lesions. J Magn Reson Imaging 2016;43:463–73 doi:10.1002/jmri.24976 pmid:26073973

    CrossRefPubMed
23. 23.↵
    2. Harrison DM,
    3. Li X,
    4. Liu H, et al

    . Lesion heterogeneity on high-field susceptibility MRI is associated with multiple sclerosis severity. AJNR Am J Neuroradiol 2016;37:1447–53 doi:10.3174/ajnr.A4726 pmid:26939635

    Abstract/FREE Full Text
24. 24.↵
    2. Nguyen TD,
    3. Wisnieff C,
    4. Cooper MA, et al

    . T2 prep three-dimensional spiral imaging with efficient whole brain coverage for myelin water quantification at 1.5 Tesla. Magn Reson Med 2012;67:614–21 doi:10.1002/mrm.24128 pmid:22344579

    CrossRefPubMed
25. 25.↵
    2. Nguyen TD,
    3. Deh K,
    4. Monohan E, et al

    . Feasibility and reproducibility of whole brain myelin water mapping in 4 minutes using fast acquisition with spiral trajectory and adiabatic T2prep (FAST-T2) at 3T. Magn Reson Med 2016;76:456–65 doi:10.1002/mrm.25877 pmid:26331978

    CrossRefPubMed
26. 26.↵
    2. Laule C,
    3. Kozlowski P,
    4. Leung E, et al

    . Myelin water imaging of multiple sclerosis at 7 T: correlations with histopathology. Neuroimage 2008;40:1575–80 doi:10.1016/j.neuroimage.2007.12.008 pmid:18321730

    CrossRefPubMedWeb of Science
27. 27.↵
    2. McCreary CR,
    3. Bjarnason TA,
    4. Skihar V, et al

    . Multiexponential T2 and magnetization transfer MRI of demyelination and remyelination in murine spinal cord. Neuroimage 2009;45:1173–82 doi:10.1016/j.neuroimage.2008.12.071 pmid:19349232

    CrossRefPubMedWeb of Science
28. 28.↵
    2. Vargas WS,
    3. Monohan E,
    4. Pandya S, et al

    . Measuring longitudinal myelin water fraction in new multiple sclerosis lesions. Neuroimage Clin 2015;9:369–75 doi:10.1016/j.nicl.2015.09.003 pmid:26594620

    CrossRefPubMed
29. 29.↵
    2. de Rochefort L,
    3. Liu T,
    4. Kressler B, et al

    . Quantitative susceptibility map reconstruction from MR phase data using Bayesian regularization: validation and application to brain imaging. Magn Reson Med 2010;63:194–206 doi:10.1002/mrm.22187 pmid:19953507

    CrossRefPubMed
30. 30.↵
    2. Liu J,
    3. Liu T,
    4. de Rochefort L, et al

    . Morphology enabled dipole inversion for quantitative susceptibility mapping using structural consistency between the magnitude image and the susceptibility map. Neuroimage 2012;59:2560–68 doi:10.1016/j.neuroimage.2011.08.082 pmid:21925276

    CrossRefPubMed
31. 31.↵
    2. Jenkinson M,
    3. Bannister P,
    4. Brady M, et al

    . Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuromage 2002;17:825–41 doi:10.1006/nimg.2002.1132 pmid:12377157

    CrossRefPubMed
32. 32.↵
    2. Chen W,
    3. Gauthier SA,
    4. Gupta A, et al

    . Quantitative susceptibility mapping of multiple sclerosis lesions at various ages. Radiology 2014;271:183–92 doi:10.1148/radiol.13130353 pmid:24475808

    CrossRefPubMed
33. 33.↵
    2. Zhang Y,
    3. Gauthier SA,
    4. Gupta A, et al

    . Longitudinal change in magnetic susceptibility of new enhanced multiple sclerosis (MS) lesions measured on serial quantitative susceptibility mapping (QSM). J Magn Reson Imaging 2016;44:426–32 doi:10.1002/jmri.25144 pmid:26800367

    CrossRefPubMed
34. 34.↵
    2. Kuhlmann T,
    3. Ludwin S,
    4. Prat A, et al

    . An updated histological classification system for multiple sclerosis lesions. Acta Neuropathol 2017;133:13–24 doi:10.1007/s00401-016-1653-y pmid:27988845

    CrossRefPubMed
35. 35.↵
    2. Wiggermann V,
    3. Hernández Torres E,
    4. Vavasour IM, et al

    . Magnetic resonance frequency shifts during acute MS lesion formation. Neurology 2013;81:211–18 doi:10.1212/WNL.0b013e31829bfd63 pmid:23761621

    Abstract/FREE Full Text
36. 36.↵
    2. Haider L

    . Inflammation, iron, energy failure, and oxidative stress in the pathogenesis of multiple sclerosis. Oxid Med Cell Longev 2015;2015:725370 doi:10.1155/2015/725370 pmid:26106458

    CrossRefPubMed
37. 37.↵
    2. Haider L,
    3. Fischer MT,
    4. Frischer JM, et al

    . Oxidative damage in multiple sclerosis lesions. Brain 2011;134:1914–24 doi:10.1093/brain/awr128 pmid:21653539

    CrossRefPubMedWeb of Science
38. 38.↵
    2. Prineas JW,
    3. Kwon EE,
    4. Cho ES, et al

    . Immunopathology of secondary-progressive multiple sclerosis. Ann Neurol 2001;50:646–57 doi:10.1002/ana.1255 pmid:11706971

    CrossRefPubMedWeb of Science
39. 39.↵
    2. Cronin MJ,
    3. Wharton S,
    4. Al-Radaideh A, et al

    . A comparison of phase imaging and quantitative susceptibility mapping in the imaging of multiple sclerosis lesions at ultrahigh field. MAGMA 2016;29:543–57 doi:10.1007/s10334-016-0560-5 pmid:27112155

    CrossRefPubMed